Follow
Dr. Maysa Suyagh
Dr. Maysa Suyagh
Associate Professor of Clinical Pharmacy / The University of Jordan
Verified email at ju.edu.jo - Homepage
Title
Cited by
Cited by
Year
Pharmacist’s knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process
M Suyagh, D Farah, RA Farha
Saudi Pharmaceutical Journal 23 (2), 147-153, 2015
1482015
Development and validation of a dried blood spot–HPLC assay for the determination of metronidazole in neonatal whole blood samples
MF Suyagh, G Iheagwaram, PL Kole, J Millership, P Collier, H Halliday, ...
Analytical and bioanalytical chemistry 397, 687-693, 2010
702010
Metronidazole population pharmacokinetics in preterm neonates using dried blood-spot sampling
M Suyagh, PS Collier, JS Millership, G Iheagwaram, M Millar, HL Halliday, ...
Pediatrics 127 (2), e367-e374, 2011
642011
Development and validation of a dried blood spot—LC–APCI–MS assay for estimation of canrenone in paediatric samples
MF Suyagh, PL Kole, J Millership, P Collier, H Halliday, JC McElnay
Journal of Chromatography B 878 (9-10), 769-776, 2010
462010
Evidence‐based medicine use in pharmacy practice: a cross‐sectional survey
R Abu Farha, E Alefishat, M Suyagh, E Elayeh, A Mayyas
Journal of evaluation in clinical practice 20 (6), 786-792, 2014
292014
Knowledge, attitude and opinion of drug misuse and abuse by pharmacy students: a cross-sectional study in Jordan
D Jaber, N Bulatova, M Suyagh, AM Yousef, M Wazaify
Tropical Journal of Pharmaceutical Research 14 (8), 1501-1508, 2015
262015
Parental views of antibiotic use in children with upper respiratory tract infections in Jordan
RA Farha, M Suyagh, L Alsakran, M Alsous, E Alefishat
Tropical Journal of Pharmaceutical Research 15 (9), 2009-2016, 2016
182016
Identification of Insulin Resistance Biomarkers in Metabolic Syndrome Detected by UHPLC-ESI-QTOF-MS
LO Alsoud, NC Soares, HM Al-Hroub, M Mousa, V Kasabri, N Bulatova, ...
Metabolites 12 (6), 508, 2022
112022
Prevalence of cardiovascular diseases risk factors among Jordanians
W Alsaud, MJ Tabbaa, VN Kasabri, MF Suyagh, MAA Alsamen, ...
Journal of the Saudi Heart Association 32 (2), 324, 2020
82020
Increased irisin versus reduced fibroblast growth factor1 (FGF1) in relation to adiposity, atherogenicity and hematological indices in metabolic syndrome patients with and …
GY Saber, V Kasabri, MI Saleh, M Suyagh, L Halaseh, R Jaber, ...
Hormone Molecular Biology and Clinical Investigation 38 (1), 20180063, 2019
72019
Cross-Sectional correlates of nesfatin and lipopolysaccharide binding protein in metabolic syndrome patients with and without prediabetes
SA Al-Qudah, V Kasabri, MI Saleh, M Suyagh, S AlAlawi, N Yasin
Hormone molecular biology and clinical investigation 36 (3), 20180035, 2018
72018
Proportional correlates of adipolin and cathepsin S in metabolic syndrome patients with and without prediabetes
V Kasabri, MI Al-Ghareeb, MI Saleh, M Suyagh, L Halaseh, I Al-Sarraf, ...
Diabetes & Metabolic Syndrome: Clinical Research & Reviews 13 (4), 2403-2408, 2019
62019
Correlates of zinc finger BED domain-containing protein 3 and ghrelin in metabolic syndrome patients with and without prediabetes
R AbuZayed, N Bulatova, V Kasabri, M Suyagh, L Halaseh, S AlAlawi
Hormone Molecular Biology and Clinical Investigation 37 (3), 20180052, 2019
62019
Correlates of resistin and retinol-binding protein 4 in metabolic syndrome patients with and without prediabetes
AA Horan, A Albsoul-Younes, V Kasabri, M Suyagh, L Halaseh, S AlAlawi
Hormone Molecular Biology and Clinical Investigation 37 (3), 20180051, 2019
62019
Perception of pharmacy students towards their community pharmacy training experience: a cross-sectional study from Jordan
R Abu Farha, E Elayeh, N Zalloum, T Mukattash, E Alefishat, M Suyagh, ...
BMC Medical Education 21, 1-7, 2021
52021
Increased lipocalin-2 vs reduced oxytocin in relation with adiposity, atherogenicity and hematological indices in metabolic syndrome patients with and without prediabetes.
KO Tofiq, N Bulatova, V Kasabri, M Suyagh, L Halaseh, S Alalawi
Bratislavske Lekarske Listy 119 (12), 762-769, 2018
52018
Potassium canrenoate treatment in paediatric patients: a population pharmacokinetic study using novel dried blood spot sampling
M Suyagh, AF Hawwa, PS Collier, JS Millership, P Kole, M Millar, ...
Journal of Hypertension 31 (9), 1901-1908, 2013
52013
Population pharmacokinetic model of canrenone after intravenous administration of potassium canrenoate to paediatric patients
M Suyagh, AF Hawwa, PS Collier, JS Millership, P Kole, M Millar, ...
British journal of clinical pharmacology 74 (5), 864-872, 2012
52012
Pharmacist’s knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process. Saudi Pharm J. 2015; 23 (2): 147-153
M Suyagh, D Farah, R Abu Farha
5
Proportional correlates of cystatin-C with pentraxin-3, visceral adiposity index and atherogenicity index of plasma but not blood indices in metabolic syndrome patients with …
MMW Al-Batsh, A Albsoul-Younes, V Kasabri, M Suyagh, S Alalawi, ...
Hormone Molecular Biology and Clinical Investigation 36 (3), 20180058, 2018
42018
The system can't perform the operation now. Try again later.
Articles 1–20